News Release 10-Sep-2024 Reports and ProceedingsEuropean Respiratory Society image: Portrait of researcher Professor Jan Hedner Credit: Jan Hedner / European Respiratory Society Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnoea (OSA), according to results of a clinical trial presented at the European Respiratory...
FEBRUARY 9TH, 2021 MEDGADGET EDITORS CARDIOLOGY, MEDICINE, NEUROLOGY Obstructive sleep apnea (OSA) impacts millions of people with wide-ranging effects that can have a serious impact on overall health. There are a number of technologies to help manage and sometimes treat the condition, including continuous positive airway pressure (CPAP) devices. Most patients end up receiving therapies that don’t treat the...
Nose and mouth sprays are a highly effective way to get medication into the body — unlike a pill, the drug does not have to pass through the acidic environment of the stomach, which can reduce its effectiveness, nor does it have to be metabolized by the liver. Instead, squirting a fine mist containing the...
